Best practices for 18F-fluciclovine PET/CT imaging of recurrent prostate cancer: a guide for technologists
FI Tade, RA Sajdak, M Gabriel… - Journal of Nuclear …, 2019 - Soc Nuclear Med
18F-fluciclovine is a Food and Drug Administration–approved PET tracer indicated for
patients suspected to have recurrent prostate cancer based on a prostate-specific antigen …
patients suspected to have recurrent prostate cancer based on a prostate-specific antigen …
Emerging Role of Fluciclovine and Other Next Generation PET Imaging Agents in Prostate Cancer Management
B Savir-Baruch, F Tade, E Henry, A Goldberg… - Current Radiology …, 2019 - Springer
Abstract Purpose of Review Prostate cancer recurrence after definitive therapy is not
uncommon. Recurrent disease is first detected by the elevation of prostate specific antigen …
uncommon. Recurrent disease is first detected by the elevation of prostate specific antigen …